• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm

By: Lowey Dannenberg, P.C. via GlobeNewswire
October 24, 2025 at 11:33 AM EDT

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

On October 16, 2025, a complaint was filed against the Company and certain of its current and former officers, alleging that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (a) the Novum LVP suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (b) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (c) Baxter’s attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (d) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (e) based on the foregoing, Baxter’s statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading.

When investors learned the truth, Baxter’s common stock declined precipitously, injuring investors.

If you suffered a loss of more than $250,000 in Baxter’s securities, and wish to participate, or learn more, click here, or please contact our attorneys at (914) 733-7256 or via email to Andrea Farah (afarah@lowey.com) or Vincent R. Cappucci Jr. (vcappucci@lowey.com).

Any investor who wishes to serve as Lead Plaintiff must act before December 15, 2025.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.

Contact:

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7234
Email: afarah@lowey.com

SOURCE: Lowey Dannenberg P.C.


Primary Logo

More News

View More
Buyback Accelerators: 3 Stocks Boosting Capacity & Spending Speed
Today 10:35 EDT
Via MarketBeat
Tickers BCS COF EPAM
Top 3 Stocks Powering Through Trump’s Tariff Policies
Today 9:18 EDT
Via MarketBeat
Topics Government
Tickers AAPL GM ISRG
Keurig Dr Pepper in the Buy Zone: It's Time to Build a Position
Today 8:08 EDT
Via MarketBeat
Tickers KDP KO NSRGY PEP
AI Demand Fuels Bullish Western Digital Forecasts
Today 7:09 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers BAC WDC
Growth Picks: 3 Low-Cost Stocks That Could Double in Value
October 27, 2025
Via MarketBeat
Tickers BIRK EQX IMCR

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.56
-0.41 (-0.18%)
AAPL  268.43
-0.38 (-0.14%)
AMD  259.90
+0.23 (0.09%)
BAC  52.90
-0.12 (-0.23%)
GOOG  267.75
-2.18 (-0.81%)
META  746.09
-4.73 (-0.63%)
MSFT  543.40
+11.88 (2.24%)
NVDA  192.47
+0.98 (0.51%)
ORCL  283.39
+1.99 (0.71%)
TSLA  460.60
+8.18 (1.81%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap